Cart
sales@molnova.com
AZD0780
CAS No. 2455427-91-3
AZD0780( —— )
Catalog No. M35805 CAS No. 2455427-91-3
AZD0780 (EX-A6975) is an oral small molecule PCSK9 inhibitor being developed by AstraZeneca as a first-in-class treatment for patients with dyslipidemia that is uncontrolled with statins alone.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 141 | Get Quote |
|
| 5MG | 217 | Get Quote |
|
| 10MG | 353 | Get Quote |
|
| 25MG | 579 | Get Quote |
|
| 50MG | 824 | Get Quote |
|
| 100MG | 1098 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAZD0780
-
NoteResearch use only, not for human use.
-
Brief DescriptionAZD0780 (EX-A6975) is an oral small molecule PCSK9 inhibitor being developed by AstraZeneca as a first-in-class treatment for patients with dyslipidemia that is uncontrolled with statins alone.
-
DescriptionPCSK9-IN-12 is a heteroaryl compound. PCSK9-IN-12has bind affinity for PCSK9with a Kd value of ＜200 nM. PCSK9-IN-12 can be used for the research of cholesterol metabolism.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2455427-91-3
-
Formula Weight414.41
-
Molecular FormulaC20H20F2N6O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (241.31 mM; Ultrasonic )
-
SMILESFC(F)Oc1cnc(N[C@H]2CC[C@@H](C2)Nc2ccc(cn2)-n2ccccc2=O)nc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Michael H. Serrano-Wu, et al. Pcsk9 inhibitors and methods of use thereof. Patent. WO2020150474A1.
molnova catalog
related products
-
(+)-Lariciresinol 4-...
(+)-Lariciresinol 4'-O-beta-D-Glucopyranosyl-(1->3)-beta-D-glucopyranoside is a natural product for research related to life sciences.
-
(1R)-(-)-Menthyl ace...
(1R)-(-)-Menthyl acetate is a derivative of L-menthol.
-
Isbufylline
Isbufylline can exert significant anti-inflammatory actions, in addition to its bronchodilator activity.
